Engineering and optimization of the miR-106b cluster for ectopic expression of multiplexed anti-HIV RNAs.
Many microRNAs (miRNAs) are encoded within the introns of RNA Pol II transcripts, often as polycistronic precursors. Here, we demonstrate the optimization of an intron encoding three endogenous miRNAs for the ectopic expression of heterologous anti-HIV-1 small interfering RNAs (siRNAs) processed from a single RNA polymerase II primary miRNA. Our expression system, designated as MCM7, is engineered from the intron-embedded, tri-cistronic miR-106b cluster that endogenously expresses miR-106b, miR-93 and miR-25. Manipulation of the miR-106b cluster demonstrated a strict requirement for maintenance of the native flanking primary miRNA (pri-miRNA) sequences and key structural features of the native miRNAs for efficient siRNA processing. As a model for testing the efficacy of this approach, we have replaced the three endogenous miRNAs with siRNAs targeting the tat and rev transcripts of human immunodeficiency virus type 1 (HIV-1). This study has enabled us to establish guidelines for optimal processing of the engineered miRNA mimics into functional siRNAs. In addition, we demonstrate that the incorporation of a small nucleolar RNA TAR chimeric decoy (snoRNA) inserted within the MCM7 intron resulted in a substantial enhancement of HIV suppression in long-term acute infectious HIV-1 challenges.
Aagaard
L A
LA
Division of Molecular Biology, Beckman Research Institute of City of Hope, Duarte, CA, USA.
Zhang
J
J
von Eije
K J
KJ
Li
H
H
Saetrom
P
P
Amarzguioui
M
M
Rossi
J J
JJ
D015152:Blotting, Northern / Q000379:methods; D002460:Cell Line; D003001:Cloning, Molecular; D015870:Gene Expression; D005796:Genes; D005818:Genetic Engineering; D015316:Genetic Therapy / Q000379:methods*; D015658:HIV Infections / Q000628:therapy*; D016325:HIV Long Terminal Repeat; D015497:HIV-1 / Q000235:genetics*; D006801:Humans; D007438:Introns; D035683:MicroRNAs / Q000235:genetics*; D012319:RNA Polymerase II / Q000235:genetics; D034741:RNA, Small Interfering / Q000235:genetics*; D014162:Transfection / Q000379:methods; D054322:tat Gene Products, Human Immunodeficiency Virus
D035683:MicroRNAs; D034741:RNA, Small Interfering; D054322:tat Gene Products, Human Immunodeficiency Virus; D012319:RNA Polymerase II
Cell. 2006 Jun 2;125(5):887-901
16751099
Curr Pharm Des. 2006;12(16):1949-61
16787240
PLoS Med. 2006 Jul;3(7):e242
16848617
Nat Methods. 2006 Sep;3(9):689-95
16929313
Nat Methods. 2006 Sep;3(9):707-14
16929316
Mol Ther. 2006 Oct;14(4):494-504
16844419
Mol Ther. 2006 Oct;14(4):485-93
16872906
FEBS J. 2006 Dec;273(23):5421-7
17076699
Genes Dev. 2002 Apr 15;16(8):948-58
11959843
Science. 2002 Apr 19;296(5567):550-3
11910072
Nat Biotechnol. 2002 May;20(5):500-5
11981565
Mol Cell. 2002 Jun;9(6):1327-33
12086629
Nature. 2002 Jul 25;418(6896):430-4
12087357
EMBO J. 2002 Sep 2;21(17):4663-70
12198168
Proc Natl Acad Sci U S A. 2002 Oct 29;99(22):14047-52
12376617
Nat Genet. 2003 Mar;33(3):401-6
12590264
J Virol. 2003 Jul;77(13):7174-81
12805416
Mol Cell. 2003 Jul;12(1):113-23
12887897
Mol Ther. 2003 Aug;8(2):196-206
12907142
Nature. 2003 Sep 25;425(6956):415-9
14508493
J Virol. 2003 Nov;77(21):11531-5
14557638
Cell. 2003 Oct 17;115(2):199-208
14567917
Cell. 2003 Oct 17;115(2):209-16
14567918
Genes Dev. 2003 Dec 15;17(24):3011-6
14681208
Science. 2004 Jan 2;303(5654):95-8
14631048
Cell. 2004 Jan 23;116(2):281-97
14744438
Mol Ther. 2006 Dec;14(6):883-92
16959541
Bioinformatics. 2007 Jan 15;23(2):142-9
17105718
EMBO J. 2007 Feb 7;26(3):775-83
17255951
Nat Rev Genet. 2007 Mar;8(3):173-84
17304245
Mol Ther. 2007 May;15(5):938-45
17311008
Mol Ther. 2007 May;15(5):878-88
17311009
Mol Ther. 2008 Mar;16(3):557-64
18180777
J Virol. 2008 Mar;82(6):2895-903
18077712
EMBO J. 2004 Oct 13;23(20):4051-60
15372072
Nature. 1998 Feb 19;391(6669):806-11
9486653
Nature. 2004 Nov 11;432(7014):235-40
15531877
Nature. 2004 Nov 11;432(7014):231-5
15531879
RNA. 2004 Dec;10(12):1957-66
15525708
Science. 2004 Nov 19;306(5700):1377-80
15550672
Nat Biotechnol. 2004 Dec;22(12):1573-8
15568018
Curr Biol. 2004 Dec 14;14(23):2162-7
15589161
Genes Dev. 2004 Dec 15;18(24):3016-27
15574589
J Virol. 2005 Feb;79(3):1645-54
15650190
EMBO J. 2005 Jan 12;24(1):138-48
15565168
Nucleic Acids Res. 2005;33(2):796-804
15687388
Mol Cells. 2005 Feb 28;19(1):1-15
15750334
Nucleic Acids Res. 2005;33(6):e62
15805121
J Virol. 2005 Jun;79(11):7050-8
15890944
Nucleic Acids Res. 2005;33(8):2697-706
15891114
Nature. 2005 Jun 9;435(7043):828-33
15944707
Nat Rev Mol Cell Biol. 2005 May;6(5):376-85
15852042
Methods Mol Biol. 2005;309:261-72
15990406
Nature. 2001 May 24;411(6836):494-8
11373684
Proc Natl Acad Sci U S A. 2001 Nov 6;98(23):12914-9
11606788
Genes Dev. 2002 Mar 15;16(6):720-8
11914277
J Virol. 2004 Mar;78(5):2601-5
14963165
J Mol Biol. 2004 May 28;339(2):327-35
15136036
Nat Rev Genet. 2004 May;5(5):396-400
15143321
Nucleic Acids Res. 2004;32(16):4776-85
15356295
Nature. 2004 Sep 16;431(7006):371-8
15372045
Genome Res. 2004 Oct;14(10A):1902-10
15364901
Gene Ther. 2005 Jul;12(14):1133-44
15750613
J Virol. 2005 Aug;79(15):9556-65
16014917
Nature. 2005 Aug 4;436(7051):740-4
15973356
Proc Natl Acad Sci U S A. 2005 Sep 13;102(37):13212-7
16141338
Nat Genet. 2005 Nov;37(11):1289-95
16200064
Nat Genet. 2005 Nov;37(11):1281-8
16200065
Mol Ther. 2005 Nov;12(5):900-9
16115802
Cell. 2005 Nov 18;123(4):631-40
16271387
Nucleic Acids Res. 2006;34(7):e53
16614444
Nature. 2006 May 25;441(7092):537-41
16724069